- Report
- March 2026
- 145 Pages
Global
From €2671EUR$2,999USD£2,296GBP
€3562EUR$3,999USD£3,062GBP
- Report
- August 2026
- 184 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- August 2026
- 196 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- August 2026
- 182 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- August 2026
- 187 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- August 2026
- 196 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- August 2026
- 185 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- August 2026
- 180 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- January 2026
- 186 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- January 2026
- 191 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- January 2026
- 180 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- January 2026
- 188 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- January 2026
- 193 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- November 2025
- 196 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- May 2026
- 182 Pages
Global
From €4008EUR$4,500USD£3,446GBP
- Report
- January 2026
- 181 Pages
Global
From €4008EUR$4,500USD£3,446GBP
- Report
- January 2026
- 180 Pages
Global
From €4008EUR$4,500USD£3,446GBP
- Report
- January 2026
- 194 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,438GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,438GBP

The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.
The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools.
Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more